1 Ainiala H Hietaharju A Loukkola J . Validity of the new American College of Rheumatology criteria for neuropsychiatric lupus syndromes: a population-based evaluation. Arthritis Rheum2001; 45: 419–423.
2.
2 Brey RL Holliday SL Saklad AR . Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology2002; 58: 1214–1220.
3.
3 Hanly JG McCurdy G Fougere L Douglas JA Thompson K . Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol2004; 31: 2156–2162.
4.
4 Sanna G Bertolaccini ML Cuadrado MJ Laing H Mathieu A Hughes GR . Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol2003; 30: 985–992.
5.
5 Sibbitt WL Brandt JR Johnson CR . The incidence and prevalence of neuropsychiatric syndromes in pediatric onset systemic lupus erythematosus. J Rheumatol2002; 29: 1536–1542.
6.
6 Boumpas DT Austin HA Fessler BJ Balow JE Klippel JH Lockshin MD . Systemic lupus erythematosus: emerging concepts. Part 1: Renal, neuropsychiatric, cardiovascular, pulmonary, and hematologic disease. Ann Intern Med1995; 122: 940–950.
7.
7 Sergent JS Lockshin MD Klempner MS Lipsky BA . Central nervous system disease in systemic lupus erythematosus. Therapy and prognosis. Am J Med1975; 58: 644–654.
8.
8 Estes D Christian CL . The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore)1971; 50: 85–95.
9.
9 Ginzler EM Diamond HS Weiner M . A multicenter study of outcome in systemic lupus erythematosus. I. Entry variables as predictors of prognosis. Arthritis Rheum1982; 25: 601–611.
10.
10 Lee P Urowitz MB Bookman AA . Systemic lupus erythematosus. A review of 110 cases with reference to nephritis, the nervous system, infections, aseptic necrosis and prognosis. Q J Med1977; 46: 1–32.
11.
11 Bernatsky S Clarke A Gladman DD . Mortality related to cerebrovascular disease in systemic lupus erythematosus. Lupus2006; 15: 835–839.
12.
12 Sibley JT Olszynski WP Decoteau WE Sundaram MB . The incidence and prognosis of central nervous system disease in systemic lupus erythematosus. J Rheumatol1992; 19: 47–52.
13.
13 Feinglass EJ Arnett FC Dorsch CA Zizic TM Stevens MB . Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine (Baltimore)1976; 55: 323–339.
14.
14 Kovacs JA Urowitz MB Gladman DD . Dilemmas in neuropsychiatric lupus. Rheum Dis Clin North Am1993; 19: 795–814.
15.
15 The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum1999; 42: 599–608.
17 DeGiorgio LA Konstantinov KN Lee SC Hardin JA Volpe BT Diamond B . A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med2001; 7: 1189–1193.
18.
18 Bluestein HG Williams GW Steinberg AD . Cerebrospinal fluid antibodies to neuronal cells: association with neuropsychiatric manifestations of systemic lupus erythematosus. Am J Med1981; 70: 240–246.
19.
19 Isenberg D Ramsey-Goldman R . Systemic Lupus International Collaborating Group – onwards and upwards. Lupus2006; 15: 606–607.
20.
20 Gladman D Urowitz M Fortin P . Systemic Lupus International Collaborating Clinics conference on assessment of lupus flare and quality of life measures in SLE. Systemic Lupus International Collaborating Clinics Group. J Rheumatol1996; 23: 1953–1955.
21.
21 Isenberg D Bacon P Bombardier C . Criteria for assessing disease activity in systemic lupus erythematosus. J Rheumatol1989; 16: 1395–1396.
22.
22 Gladman D Ginzler E Goldsmith C . Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol1992; 19: 1820–1821.
23.
23 Gladman DD Goldsmith CH Urowitz MB . Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol1992; 19: 608–611.
24.
24 Gladman DD Goldsmith CH Urowitz MB . Sensitivity to change of 3 Systemic Lupus Erythematosus Disease Activity Indices: international validation. J Rheumatol1994; 21: 1468–1471.
25.
25 Gladman D Ginzler E Goldsmith C . The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
26.
26 Gladman DD Urowitz MB Goldsmith CH . The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum1997; 40: 809–813.
27.
27 Gladman DD Goldsmith CH Urowitz MB . The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol2000; 27: 373–376.
28.
28 Urowitz MB Gladman DD . Atherosclerosis and lupus: the SLICC Study. Lupus2007; 16: 925–928.
29.
29 Hanly JG Urowitz MB Sanchez-Guerrero J . Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum2007; 56: 265–273.
30.
30 Hanly JG Urowitz MB Siannis F . Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis: results from an international inception cohort study. Arthritis Rheum2008; 58: 843–853.
31.
31 Hanly JG Urowitz MB Su L . Systemic Lupus International Collaborating Clinics. Short-term outcome of neuropsychiatric events in systemic lupus erythematosus upon enrollment into an international inception cohort study. Arthritis Rheum2008; 59: 721–729.
32.
32 Hanly JG Hong C Smith S Fisk JD . A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum1999; 42: 728–734.
33.
33 Menon S Jameson-Shortall E Newman SP Hall-Craggs MR Chinn R Isenberg DA . A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus. Arthritis Rheum1999; 42: 735–741.
34.
34 Reveille JD . Predictive value of autoantibodies for activity of systemic lupus erythematosus. Lupus2004; 13: 290–297.
35.
35 Bonfa E Golombek SJ Kaufman LD . Association between lupus psychosis and anti-ribosomal P protein antibodies. N Engl J Med1987; 317: 265–271.